[Skip to Content]
[Skip to Content Landing]
Views 885
Citations 0
JAMA Clinical Challenge
July 4, 2017

A Large Adrenal Tumor With Marked 18F-Fluorodeoxyglucose Uptake

Author Affiliations
  • 1Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, Marseille, France
  • 2Department of Endocrine Surgery, Conception University Hospital, Aix-Marseille University, Marseille, France
  • 3Eunice Kennedy Shriver National Institute of Child Health & Human Development, Section on Medical Neuroendocrinology, National Institutes of Health, Bethesda, Maryland
JAMA. 2017;318(1):84-85. doi:10.1001/jama.2017.6326

A 56-year-old woman was referred for evaluation of an incidentally discovered adrenal mass. She experienced no symptoms of weight loss, headache, sweating, palpitations, pallor, anxiety, menstrual abnormalities, or mood changes; had no known history of cancer or hypertension; and was not taking any medications. On physical examination, her blood pressure was 135/73 mm Hg, and her heart rate was 82/min. There was no truncal or facial obesity, acne, striae, hirsutism, or proximal muscle weakness. Laboratory analysis showed normal blood cell counts and levels of electrolytes, liver enzymes, and lactate dehydrogenase. Further biochemical evaluation revealed normal levels of plasma and urinary cortisol, serum aldosterone and 17-hydroxyprogesterone, and urinary metanephrines. A computed tomography (CT) scan revealed a 5.5 × 4.3–cm left adrenal tumor with heterogeneous appearance, a hypodense central area, and irregular margins, with a density of 36 Hounsfield units (HU). Relative and absolute adrenal washout values (a measure of the disappearance of contrast media from a mass after 10 minutes) were 23% and 47%, respectively. A positron emission tomography (PET)/CT scan using 18F-fluorodeoxyglucose (18F-FDG) was performed for further tumor characterization (Figure).

First Page Preview View Large
First page PDF preview
First page PDF preview